|
Category
|
Subgroups
|
N of patients
|
(%)
|
|---|
|
Age at time of diagnosis
|
<40 years
|
188
|
6,6
|
|
40-49
|
562
|
19,6
|
|
50-59
|
778
|
27,2
|
|
60-69
|
709
|
24,8
|
|
70-79
|
423
|
14,8
|
|
≥80
|
202
|
7,1
|
|
Year of diagnosis
|
2009
|
489
|
17,1
|
|
2010
|
448
|
15,7
|
|
2011
|
468
|
16,4
|
|
2012
|
483
|
16,9
|
|
2013
|
500
|
17,5
|
|
2014
|
474
|
16,6
|
|
Stage at diagnosis
|
Stage 0
|
47
|
1,6
|
|
Stage I
|
1063
|
37,1
|
|
Stage II
|
1174
|
41,0
|
|
Stage III
|
357
|
12,5
|
|
Stage IV
|
158
|
5,5
|
|
Stage unknown
|
63
|
2,2
|
|
Tumor Grade
|
Grade 1
|
319
|
11,1
|
|
Grade 2
|
1378
|
48,1
|
|
Grade 3
|
1126
|
39,3
|
|
Grade unknown
|
39
|
1,4
|
|
Multiple tumors
|
No
|
2733
|
95,5
|
|
2+
|
129
|
4,5
|
|
Treatmenta
|
Breast Conserving Surgery
|
1374
|
48,0
|
|
Mastectomy
|
1311
|
45,8
|
|
Radiotherapy
|
2354
|
82,3
|
|
Chemotherapy
|
1296
|
45,3
|
|
Hormonal therapy
|
2344
|
81,9
|
|
Morphology
|
Ductal
|
2118
|
74,0
|
|
Lobular
|
337
|
11,8
|
|
Other
|
407
|
14,2
|
- aSome patients receive multiple different treatment interventions within each subgroup (surgery or systemic therapy) during their follow-up period
